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1. Introduction  
Severe hemorrhage and infection causing significant morbidity and mortality limited the 
use of cesarean section until the twentieth century, when important advances in aseptic, 
surgical, and anesthetic techniques improved the safety of this procedure for both woman 
and fetus [1-3].  
The most common indications for cesarean delivery include dystocia, prior cesarean 
delivery, malpresentation, multiple gestation, fetal distress (nonreassuring fetal status), and 
maternal request [1-3]. Since late 70’s, a progressive increase in the cesarean delivery rates 
has been observed worldwide and several factors are associated with this finding: maternal, 
obstetric, fetal, medicolegal, and social factors are pivotal for this increment. Actually, 
cesarean delivery rates have increased to around 30% in the last decade [1-3]. Notably, 
cesarean delivery rates are likely to increase further as women are requesting an elective 
cesarean delivery even for their first baby. Although controversial, the American College of 
Obstetricians and Gynecologists (ACOG) has suggested that it is ethical for an obstetrician 
to perform an elective cesarean delivery if the physician believes that the cesarean delivery 
promotes the health of the mother and fetus more than a vaginal delivery. 
The selection of regional or general anesthesia for cesarean delivery depends on the 
experience of the anesthesiologist, past medical history of the patient, indications and 
urgency of the cesarean delivery, maternal status, and desires of the patient. Past medical, 
surgical, and obstetric history, presence or absence of labor, and available resources should 
also be considered by the anesthesiologist [4-6]. Considering these issues, the main aims of 
this chapter are to discuss the most important topics involved in anesthesia for cesarean 
delivery and the most recent scientific evidences regarding techniques and perioperative 
management of obstetric patients. We emphasize that this chapter is only a brief review 
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focusing on main issues involved in anesthesia for cesarean delivery and more 
comprehensive reviews and recommendations are available elsewhere [4-6]. 
2. Perianesthetic evaluation of the obstetric patient 
2.1 Preanesthetic evaluation 
All women admitted for labor and delivery are potential candidates for the emergency 
administration of anesthesia. Considering this fact, the anesthesiologist ideally should 
evaluate every patient shortly after admission. The anesthesiologist should conduct a 
focused history and physical examination before providing anesthesia care. This should 
include, but should be not limited to, a maternal health and anesthetic history, a relevant 
obstetric history, a baseline blood pressure measurement, allergies, and performance of an 
airway, heart, and lung examination [7]. When a neuraxial anesthetic is planned, the 
patient’s back should also be examined. Ideally, for high-risk women, preanesthetic 
evaluation should occur in the late second or early third trimester. This practice offers the 
opportunity to provide women with information, solicit further consultations, optimize 
medical conditions, and discuss plans and preparations for the upcoming delivery, perhaps 
in a multidisciplinary basis [8,9]. In some cases, the urgency or emergency of the situation 
allows limited time for evaluation before induction of anesthesia. Nevertheless, essential 
information must be obtained, and risks and benefits of anesthetic management decisions 
should be discussed on a case-by-case basis. 
Usually, obtaining an informed consent is strongly recommended [10]. The ethical issues in 
obtaining consent from the obstetric patient can be challenging considering the potential 
clinical situations, such as the pain and stress of labor and sudden changes in maternal and 
fetal status, sometimes requiring emergency care. Nevertheless, there is general consensus 
that pregnant women appear to want more rather than less information regarding the risks 
of anesthetic interventions during a preanesthetic evaluation. Women usually should be 
aware of the following neuraxial anesthetic risks: the possibility of intraoperative discomfort 
and a failed/partial blockade, the potential need to convert to general anesthesia, the 
presence of weak legs, hypotension episodes associated to discomfort, and the occurrence of 
an unintentional dural puncture (whenever an epidural technique was used) [11]. Backache 
and urinary retention could be considered for discussion, but the risk for paraplegia should 
not to be routinely addressed unless the patient specifically asked about it [11]. Finally, and 
most important, anesthesiologists are encouraged to discussion of anesthetic risks and 
techniques and use informed consent as an opportunity to establish a closer patient-
physician relationship rather than a simple tool to avoid litigation.  
2.2 Fasting recommendations and aspiration prophylaxis 
Although there is a lack of data regarding the relationship between recent food intake and 
subsequent aspiration pneumonitis, the patient should be always asked about oral intake 
and fasting period. Gastric emptying of clear liquids during pregnancy probably occurs 
relatively quickly since the residual content of the stomach does not appear to be different 
from baseline fasting levels in nonlaboring pregnant women [12,13]. The uncomplicated 
patient undergoing elective cesarean delivery may drink modest amounts of clear liquids 
(water, fruit juices without pulp, clear tea, etc) up to 2 hours before induction of anesthesia 
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[6]. The volume of liquid ingested is less important than the absence of particulate matter. 
Women with additional risk factors for aspiration (e.g., morbid obesity, diabetes, difficult 
airway), or laboring women at increased risk for cesarean delivery may have further 
restrictions of oral intake [6]. Routinely, ingestion of solid foods should be avoided during 
labor and in women undergoing elective cesarean delivery. A fasting period for solids of 6 
to 8 hours is still recommended [6].  
In women scheduled to cesarean section and considered to be in high-risk for aspiration, a 
pharmacological prophylaxis should be considered if time permits. The literature does not 
sufficiently examine the relationship between reduced gastric acidity and the frequency of 
emesis, pulmonary aspiration, morbidity, or mortality in obstetric patients who have 
aspirated gastric contents. Evidence supports the efficacy of preoperative nonparticulate 
antacids (0.3 M sodium citrate) in decreasing gastric acidity during the peripartum period, 
without affecting gastric volume [14]. Additionally, the literature suggests that H2 receptor 
antagonists such as ranitidine or famotidine are effective in decreasing gastric acidity in 
obstetric patients and supports the efficacy of metoclopramide in reducing peripartum 
nausea and vomiting [15]. Notably, intravenously administered H2 receptor antagonists and 
metoclopramide require at least 30 to 45 minutes to effectively reduce gastric acidity [15]. 
Proton pump inhibitors such as omeprazole can achieve a higher gastric pH than the H2 
receptor antagonist ranitidine [16], although ranitidine combined with sodium citrate is 
more cost effective [17].  
2.3 Equipment and facilities in obstetric anesthesia 
Labor and delivery units may be adjacent to or distant from the operating rooms. 
Nonetheless, equipment, monitoring material, facilities, and support personnel available in 
the obstetric operating room should be comparable to those available in the main operating 
room [6]. In addition, personnel and equipment should also be available to care for obstetric 
patients recovering from major neuraxial or general anesthesia and postoperative (post-
cesarean) recovery unit should be completely equipped as well. Resources for the conduct 
and support of neuraxial anesthesia and general anesthesia should include those necessary 
for the basic delivery of anesthesia and airway management as well as those required to 
manage complications. The immediate availability of these resources is essential, given the 
frequency and urgency of the anesthesia care provided. Equipment and supplies should be 
checked on a frequent and regular basis and the necessary drugs, including vasopressors, 
emergency medications, and drugs used for general and neuraxial anesthesia should be 
promptly available [6].  
Additionally, attention should be given to the availability and accurate functioning of 
monitors for anesthesia and the management of potential complications (e.g., failed 
intubation, cardiopulmonary arrest, inadequate analgesia, significant hypotension or 
bradycardia, respiratory depression, pruritus, vomiting, etc) [6]. Basic monitoring includes 
maternal pulse oximetry, electrocardiogram (ECG), noninvasive blood pressure monitoring 
and fetal heart rate (FHR) monitoring. Invasive hemodynamic monitoring should be 
considered in women with cardiovascular diseases, refractory hypertension, or other 
specific situations. Bispectral index monitors or other depth of anesthesia monitors have 
received only limited evaluation in women undergoing cesarean delivery but could be 
considered in some situations [18].  
www.intechopen.com
 
Cesarean Delivery 
 
72
3. Anesthesia for cesarean delivery 
3.1 Regional versus general anesthesia: what are the main evidences? 
Neuraxial techniques (spinal, epidural, combined spinal-epidural – CSE) are the preferred 
methods of providing anesthesia for cesarean delivery as compared to general or local 
anesthesia. Notably, more recently, neuraxial anesthesia is administered to some women 
who would have received general anesthesia in the past. For example, umbilical cord 
prolapse, placenta previa, some cardiovascular diseases and severe preeclampsia are no 
longer considered absolute indications for general anesthesia. Several studies and surveys 
indicated a progressive increase in the use of neuraxial anesthesia, especially spinal 
anesthesia, for both elective and emergency cesarean deliveries and similar increases have 
been observed in both developed and developing countries [19]. Table 1 describes the main 
factors involved in the process of selection and indication of anesthetic techniques for 
cesarean delivery. 
 
Regional (neuraxial) versus general anesthesia for cesarean delivery – main indications 
 
Regional (neuraxial) anesthesia: 
 - Risk factors for difficult airway or aspiration 
 - Maternal desire to witness birth and/or avoid general anesthesia 
 - Improved postoperative analgesia (neuraxial opioids) 
 - Presence of comorbid conditions 
 - Reduced fetal drug exposure and blood loss 
 - Allows presence of husband or support person 
General anesthesia: 
 - Presence of comorbid conditions that contraindicate a neuraxial technique 
 - Insufficient time to induce neuraxial anesthesia for urgent delivery  
- Failure of neuraxial technique 
 - Maternal refusal or failure to cooperate with neuraxial technique 
 - Planned of more complex surgical procedures during cesarean delivery (e.g. ex-
utero intrapartum treatment (EXIT) procedure) 
Table 1. Main factors involved in the selection of anesthetic techniques for cesarean delivery 
The greater use of neuraxial anesthesia for cesarean delivery has been attributed to several 
factors, such as the growing use of epidural techniques for labor analgesia, improvement in 
the quality of neuraxial anesthesia with the addition of an opioid or other adjuvants to the 
local anesthetic, the risks of airway complications during general anesthesia in obstetric 
patients, the need for limited neonatal drug transfer, the ability of the mother to remain 
awake to experience childbirth, presence of a support person in the operating room, lack of 
experience of the anesthesiologists to provide general anesthesia in the obstetric setting and 
several others [20-23]. 
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When choosing regional or general anesthesia for cesarean delivery, we should always 
consider both maternal and neonatal outcomes. Maternal outcome studies have primarily 
focused on maternal morbidity and mortality, and neonatal outcome studies have focused 
essentially on umbilical cord pH, Apgar score, the need for ventilatory assistance at birth, 
and neurobehavioral scores.  
Maternal mortality following general anesthesia has been a primary factor for the 
transition toward greater use of neuraxial anesthesia for cesarean delivery in the last few 
decades. Notably, maternal outcome seems to be better with regional anesthesia than with 
general anesthesia. Hawkins and colleagues compared the anesthesia-related maternal 
mortality rate from 1979 to 1984 with that for the period from 1985 to 1990 in the United 
States and found that the case-fatality risk ratio for general versus neuraxial anesthesia was 
as high as 16.7 in the years 1985 to 1990 [24]. The reason for this difference is primarily 
related to the respiratory system of the parturient since difficult tracheal intubation is 10 
times higher in the parturient than in the general population and hypoxemia develops 
faster during periods of apnea. Of interest, these data may overstate the relative risk of 
general anesthesia, because this form of anesthesia is used principally when neuraxial 
anesthetic techniques are contraindicated for medical reasons and/or may reflect the 
growing acceptance of performing neuraxial techniques in parturients with significant 
comorbidities [21,22]. Importantly, although general anesthesia is still correlated with 
higher incidence of maternal deaths as compared to regional anesthesia, a recent report 
suggests that a significant reduction in general anesthesia-related deaths occurred in the 
recent years [25]. 
Of note, airway management experience is decreasing in the obstetric setting. Hawthorne 
and colleagues found that the incidence of failed tracheal intubation increased from 1 in 250 
in 1984 to 1 in 300 in 1994 [26]. In a recent review of maternal mortality causes, Mhyre and 
colleagues found that “airway problems” is still a leading cause of maternal mortality, but 
that the problems occurred mostly during emergence or tracheal extubation [27]. 
Maternal morbidity is also lower with the use of neuraxial anesthesia techniques than with 
general anesthesia. In a systematic review of controlled trials comparing major maternal and 
neonatal outcomes with the use of neuraxial anesthesia and general anesthesia for cesarean 
delivery, Afolabi and colleagues found less maternal blood loss and shivering but more 
nausea in the neuraxial group [20]. Prospective audits of post-cesarean delivery outcomes 
have indicated that in the first postoperative week, women who received neuraxial 
anesthesia had less pain, gastrointestinal stasis, coughing, fever, and depression and were 
able to breast-feed and ambulate more quickly than women who received general anesthesia 
[23]. 
Although neonatal outcome seems to be better when regional anesthesia is used, differences 
among diverse anesthetic techniques are not so clear. Apgar and neonatal neurobehavioral 
scores are relatively insensitive measures of neonatal well-being, and umbilical cord blood 
gas and pH measurements may reflect an obstetric bias (indication for the cesarean delivery 
rather than differences in anesthetic techniques). Some previous studies have found that 
umbilical artery pH was greater in the neonate delivered with general anesthesia, but 
clinical parameters (e.g., Apgar score and the need for assisted ventilation) were better when 
regional anesthesia was used [28]. The acidemia found following regional anesthesia seems 
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to be increased after spinal as compared to epidural anesthesia, but has not been related to 
any clinically significant neonatal complication [20,28].  
Therefore, the decision to use a particular anesthetic technique for cesarean delivery should 
be individualized and based on several factors. These should include anesthetic, obstetric, or 
fetal risk factors, urgency, the preferences of the patient, and the judgment of the 
anesthesiologist. Neuraxial techniques are usually recommended and preferred to general 
anesthesia for most cesarean deliveries. For these reasons, most elective cesarean deliveries 
are now performed under regional anesthesia [29]. 
3.2 Spinal, epidural, combined spinal-epidural or general anesthesia 
Spinal anesthesia is commonly used rather than epidural anesthesia for elective cesarean 
delivery because with spinal anesthesia the speed of onset is quicker, the quality of 
anesthesia is considered to be superior and the failure rate is lower. Riley and colleagues 
found that spinal anesthesia leads to a more efficient utilization of operating room time than 
epidural anesthesia because time until skin incision is faster with spinal anesthesia [30]. The 
most common complication from spinal anesthesia is hypotension, which may explain the 
decreased umbilical artery pH as compared with both epidural and general anesthesia [31]. 
The spinal anesthesia is a simple and reliable technique that allows visual confirmation of 
correct needle placement (by visualization of cerebrospinal fluid leak) and is technically 
easier to perform than the epidural. Spinal anesthesia provides a rapid onset of dense 
blockade that is typically more profound than that provided with an epidural technique, 
resulting in a reduced need for supplemental intravenous analgesics or conversion to 
general anesthesia [30,32,33]. Considering that a smaller amount of local anesthetic is 
needed to establish a functional spinal blockade, spinal anesthesia is associated with 
negligible maternal risk for systemic local anesthetic toxicity and with minimal drug transfer 
to the fetus, as compared to epidural and general anesthesia [34]. Given these advantages, 
spinal anesthesia is now the most commonly used anesthetic technique for cesarean delivery 
worldwide [19,35].  
As commonly used for other conventional surgical procedures, the spinal technique should 
be performed at the L3 to L4 interspace or below. These interspaces are used to avoid the 
potential for spinal cord trauma. Spinal anesthesia is usually administered as a single-
injection procedure through a non-cutting, pencil-point needle that is usually 25-gauge or 
smaller. A number of different needle designs are available and the size and design of the 
needle tip affect the incidence and severity of post-dural puncture headache (PDPH). For 
that reason, if spinal anesthesia is chosen, small pencil-point spinal needles should be used 
instead of larger cutting-bevel spinal needles [36]. 
Continuous spinal anesthetic technique can be used in some circumstances, especially in the 
setting of an unintentional dural puncture with an epidural needle. Additionally, intentional 
continuous spinal anesthesia may also be desirable in certain settings, when the reliability of 
a spinal technique and the ability to precisely titrate the initiation and duration of anesthesia 
are recommended (e.g., morbidly obese patients or some cardiovascular diseases). However, 
technical difficulties, catheter failures, concerns about the risks for neurological 
complications and a higher incidence of post-dural puncture headache severely restrict this 
technique from a widespread use [37,38].   
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The overall use of epidural anesthesia for elective cesarean delivery has decreased, in part 
because the resulting block is less reliable than that provided by spinal anesthesia. 
Conversely, the use of epidural anesthesia for nonelective cesarean delivery has increased, 
primarily as a result of the greater use of epidural analgesia during labor [30]. Although 
medications used in the spinal and epidural spaces are identical, epidural local anesthetic 
and opioid doses are up to 10 times greater than doses given spinally leading to concerns 
regarding toxicity and efficacy. Contrariwise, advantages of the epidural technique include 
a slower onset of sympathetic blockade, which may allow compensatory mechanisms to 
attenuate the severity of hypotension episodes [30]. Furthermore, a catheter-based technique 
also allows titration of the level and duration of anesthesia and continuous post-cesarean 
delivery analgesia. 
The CSE technique incorporates the rapid and predictable onset of a spinal blockade with 
the ability to augment anesthesia by injection of additional drug through the epidural 
catheter [39-41]. In 1981, Brownridge [39] reported the first use of the CSE technique for 
cesarean delivery through separate spinal and epidural needles introduced at different 
interspaces. Carrie and O'Sullivan [40] subsequently reported the needle-through-needle 
technique via a single interspace for cesarean delivery, which has become the most 
popular technique. More recently, Davies and colleagues compared CSE with epidural 
anesthesia alone for elective cesarean delivery and reported more rapid onset, greater 
motor blockade, and lower pain scores at delivery in the CSE group [41]. The main 
disadvantages of CSE techniques are an untested epidural catheter and hypotension [42]. 
Additionally, the CSE technique is certainly more time-consuming as compared to spinal 
anesthesia only.  
An alternative CSE technique is the extradural volume extension (EVE) technique [43-45]. In 
this technique, spinal administration of a small dose of local anesthetic is followed by the 
administration of saline through the epidural catheter. Although there were conflicting 
findings, this technique has been related to a higher rostral spread of the blockade [43-45]. 
Table 2 demonstrates the main differences regarding the various neuraxial anesthetic 
techniques for cesarean delivery. With all neuraxial techniques, an adequate sensory level of 
anesthesia is essential to minimize maternal pain and avoid the urgent need for 
administration of general anesthesia. Because motor nerve fibers are typically larger and 
more difficult to block, the complete absence of hip flexion and ankle dorsiflexion most 
likely indicates that a functional sensory and sympathetic block is also present in a similar 
(primarily lumbosacral) distribution. However, because afferent nerves innervating 
abdominal and pelvic organs accompany sympathetic fibers that ascend and descend in the 
sympathetic trunk (T5 to L1), a sensory block that extends rostrally from the sacral 
dermatomes to T4 should be the goal for cesarean delivery anesthesia [46-48]. The majority 
of anesthesiologists use the absence of cold temperature sensation to a T4 level to indicate an 
adequate blockade height for cesarean delivery [46-48]. Alternatively, a T6 blockade to touch 
may provide a pain-free cesarean delivery for most parturients and could be used as a 
reference. Because the undersurface of the diaphragm (C3 to C5) and the vagus nerve may be 
stimulated by surgical manipulation during cesarean delivery [49], maternal discomfort and 
other symptoms, particularly nausea and vomiting may occur despite a T4 level of blockade. 
The use of systemic and especially neuraxial opioids are effective in preventing or 
alleviating these symptoms [49,50].  
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Technique Advantages Disadvantages  
Spinal anesthesia Technically simple Limited duration 
 
Rapid onset and dense 
blockade 
Limited level block titration 
  
Low doses of local 
anesthetic required 
Increased incidence of 
hypotension 
   
Epidural anesthesia 
No dural puncture is 
required 
Slow onset of surgical 
anesthesia 
 
Ability to titrate extent of 
sensory blockade  
Higher incidence of failure 
  
 Continuous perioperative 
anesthesia  
High doses of local 
anesthetic required 
   
CSE* anesthesia  
Low doses of local 
anesthetic and opioid  
Delayed verification of  
 
Rapid onset and dense 
blockade 
functioning epidural 
catheter 
  
Ability to titrate extent of 
sensory blockade  
Technique slightly more 
difficult  
  
Continuous perioperative 
anesthesia 
Time consuming  
*CSE = Combined spinal-epidural anesthesia. 
Table 2. Main advantages and disadvantages regarding type of neuraxial anesthesia for 
Cesarean Delivery 
The choice of local anesthetic agent (and adjuvants) used to provide spinal anesthesia 
depends on the expected duration of the surgery, the postoperative analgesia plan, and the 
preferences of the anesthesiologists. For cesarean delivery, the local anesthetic agent of 
choice is typically bupivacaine since its spinal administration usually results in a dense 
block of long duration. However, several different doses of bupivacaine have been 
described in the literature and the dose of spinal bupivacaine that has been successfully 
used for cesarean delivery ranges from 4.5 to 15 mg [40,46,49]. In general, pregnant women 
require smaller doses of spinal local anesthetic as compared to nonpregnant women. 
Reasons include a smaller CSF volume in pregnancy, rostral movement of hyperbaric local 
anesthetic in the supine pregnant patient, and the greater sensitivity of nerve fibers to the 
local anesthetic during pregnancy [51]. Overall, the mass of local anesthetic, rather than the 
concentration or volume, is thought to influence the spread of the resulting blockade [52]. 
However, the specific influence of the dose and baricity on the efficacy of the block is 
somewhat controversial and may be influenced by other factors, such as co-administration 
of neuraxial opioids. 
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More recent data suggest that lower anesthetic doses can be used, although there is some 
controversy regarding recommendations. The anesthesiologist should consider whether 
adjuvant drugs will be used and whether the risks of giving supplemental analgesia or 
conversion to general anesthesia that are associated with low doses of bupivacaine outweigh 
the potential benefits (i.e., less hypotension, faster recovery) [53-57]. For a single-shot spinal 
anesthesia for cesarean delivery, most anesthesiologists use a dose of bupivacaine between 
10 and 15 mg, in combination with opioids, sufentanil or fentanyl and morphine.  
Conventional doses of hyperbaric bupivacaine are most often used to provide CSE 
anesthesia for cesarean delivery. However, a satisfactory block has been reported with plain 
bupivacaine drug doses as low as 4.5 mg [57]. Nonetheless, the CSE technique may use a 
lower dose of spinal bupivacaine (7.5 to 10 mg) followed by incremental injection of local 
anesthetic through the epidural catheter to achieve a T4 level of anesthesia [43,44], a 
procedure called sequential CSE. The purported advantage of this approach is a lower 
incidence of hypotension. With the sequential CSE technique, Thoren and colleagues 
observed a more gradual onset of hypotension and a lower initial anesthesia level with the 
spinal dose [44]. However, all parturients in the CSE group required additional doses of 
local anesthetic through the epidural catheter. The sequential CSE technique may be of 
particular advantage in certain high-risk parturients (e.g., significant cardiac disease) in 
whom avoidance of severe hypotension is pivotal. 
Finally, the most common local anesthetic used for the initiation and maintenance of 
epidural anesthesia for cesarean delivery is 2% lidocaine with epinephrine. The epidural 
administration of lidocaine in concentrations less than 2%, or without the addition of 
epinephrine (which independently augments the analgesia through alpha-adrenergic 
receptor blockade), may result in anesthesia that is inadequate for surgery [58]. Surgical 
anesthesia can also be produced with epidural administration of 0.5% bupivacaine. 
Nevertheless, the slow onset of blockade and the risk of cardiovascular toxicity from 
unintentional intravascular injection or systemic absorption limit the contemporary use of 
this agent. The single-isomer, levorotatory local anesthetics, 0.5% to 0.75% ropivacaine and 
0.5% levobupivacaine, may be preferable to racemic bupivacaine because of their better 
safety profiles. Except for the safety profile, there are no significant clinical advantages to 
these single-isomer local anesthetics when equipotent doses are administered. Similarly to 
spinal anesthesia, opioids (sufentanil or fentanyl and morphine) are also usually 
administered in combination with local anesthetics.   
Although neuraxial techniques are typically preferred when anesthesia is provided for 
cesarean delivery, there are some clinical situations in which the administration of general 
anesthesia is considered the most appropriate option. The basic elements for preparation 
and care of the obstetric patient undergoing cesarean delivery also apply to the patient 
undergoing general anesthesia. The preanesthetic evaluation should focus on assessment of 
physical characteristics, particularly airway features, and comorbidities. Pregnancy-induced 
changes in the upper airway may be exacerbated during labor [59]. Importantly, failed 
intubation, failed ventilation and oxygenation, and pulmonary aspiration of gastric contents 
remain leading anesthesia-related causes of maternal death. Table 3 describes the main 
recommendations to general anesthesia for cesarean delivery.  
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Brief algorithm of preparation to general anesthesia for cesarean delivery 
 
1. Perform preanesthetic assessment and obtain informed consent; 
2. Prepare necessary medications and check equipment and monitors; 
3. Perform a “time-out” to verify patient identity, position, operative site, and procedure; 
4. Place patient supine with left uterine displacement; 
5. Consider the use of a nonparticulate antacid orally within 20 minutes before induction or 
metoclopramide 10 mg and/or ranitidine 30 mg intravenously more than 30 minutes before 
induction; 
6. Administer antibiotic prophylaxis (preferentially before skin incision); 
7. Initiate monitoring (electrocardiogram, non-invasive arterial pressure monitoring and 
pulse oximetry); 
8. Provide 100% oxygen with a tight-fitting face mask for 3 minutes or longer. Alternatively, 
instruct the patient to take 4 to 8 vital-capacity breaths immediately before induction of 
anesthesia; 
9. After the abdomen has been prepared and operative drapes are in place, verify that the 
surgeon and assistant are ready to begin surgery; 
10. Initiate rapid-sequence induction (thiopental 4 to 6 mg/kg or propofol 1.5 to 2.5 mg/kg 
and succinylcholine 1 mg/kg; wait up to 45 seconds; The use of cricoid pressure is still 
recommended; 
11. Perform endotracheal intubation. Confirm correct placement of endotracheal tube by 
using capnography; 
12. Provide maintenance of anesthesia (usually by using volatile anesthetics);  
13. Treat hypotension episodes by using phenylephrine or ephedrine; 
14. Observe and support delivery of baby; 
15. Begin a small bolus (up to 3 units) followed by a continuous infusion of oxytocin; 
consider other uterotonic agents (e.g., methylergometrine, misoprostol, prostaglandin F2α) 
if uterine tone is inadequate. Monitor cautiously the amount of blood loss; 
16. Adjust maintenance anesthesia technique after delivery of the infant (reduced 
concentration of a volatile anesthetic to avoid a significant reduction in the uterine tonus); 
17. Consider the high risk of awareness and recall in these patients. Cogitate administration 
of benzodiazepines (e.g., midazolam); 
18. Provide adequate multimodal analgesia and prophylaxis for postoperative nausea and 
vomiting; 
19. Perform extubation when neuromuscular blockade is fully reversed and the patient is 
awake and responds to commands; 
20. Evaluate postoperative signs and symptoms (e.g., pain, nausea, vomiting, shivering, etc).  
OBS: This algorithm may need to be modified accordingly case-by-case circumstances (e.g., emergency 
care for cesarean delivery).  
Table 3. Main recommendations to general anesthesia for cesarean delivery 
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3.3 Hemodynamic monitoring: main techniques and recent advances 
During cesarean delivery with neuraxial anesthesia, ECG changes have a reported incidence 
of 25% to 60% and are believed to be due to hyperdynamic circulation, circulating 
catecholamines, or altered hormone concentration ratios [60,61]. However, the significance 
of the ECG findings as an indicator of cardiac pathology remains controversial, but 
measurement of cardiac troponin indicates that rarely obstetric patients experience 
myocardial ischemia [62]. In a prospective study of 254 healthy women undergoing cesarean 
delivery with spinal anesthesia, Shen and colleagues have shown that the incidence of first- 
and second-degree atrioventricular block was 3.5% for each, severe bradycardia was 6.7%, 
and multiple premature ventricular contractions was 1.2%. The investigators speculated that 
a relative increase in parasympathetic activity occurred as a result of spinal blockade of 
cardiac sympathetic activity. Most of the dysrhythmias were transient and resolved 
spontaneously [63]. However, prompt management with vasoactive drugs should be 
performed if dysrhythmias persist. 
An indwelling urinary catheter is used in almost all women undergoing cesarean delivery 
[64]. A urinary catheter helps avoid overdistention of the bladder during and after surgery. 
In cases of hypovolemia and/or oliguria, a collection system that allows precise 
measurement of urine volume should be used. 
In regard to central invasive hemodynamic monitoring, there is insufficient literature to 
examine whether pulmonary artery catheterization or minimally invasive methods to 
evaluate cardiac output (pulse-wave analysis methods) are associated with improved 
maternal, fetal, or neonatal outcomes in women with pregnancy-related hypertensive 
disorders [65]. Additionally, there is an important lack of evidence regarding the 
management of obstetric patients with central venous catheterization. However, the routine 
use of pulmonary artery catheterization, pulse-wave analysis methods to evaluate cardiac 
output or central venous does not reduce maternal complications in severely preeclamptic 
women [6]. Therefore, the decision to perform invasive hemodynamic monitoring should be 
individualized and based on clinical indications that include the patient’s medical history 
and cardiovascular risk factors.  
3.4 Intravenous fluid replacement and preloading 
Numerous techniques have been attempted to prevent hypotension following spinal 
anesthesia, with varying success. The most important preventive measure is to ensure left 
uterine displacement so as to avoid the supine hypotensive syndrome [66]. Prehydration or 
preloading is not necessarily an effective measure to prevent hypotension and several 
strategies of prehydration have been used elsewhere [67-69]. Some studies have found a 
smaller incidence of hypotension in the prehydrated patients as compared with the control 
(no prehydrated) patients. However, the total amount of fluid and vasoconstrictors, and the 
severity of the hypotension usually not differ between groups [67-69]. Nevertheless, 
neonatal outcomes, as measured by Apgar score and umbilical cord blood gas and pH 
measurements, are improved when the parturient is prehydrated [70]. Although there are 
some conflicting findings, the literature still supports the use of intravenous fluid 
preloading for spinal anesthesia since it seems to reduce the frequency of maternal 
hypotension when compared with no fluid preloading. Of note, though fluid preloading 
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reduces the frequency of maternal hypotension, initiation of spinal anesthesia should not be 
delayed to administer a fixed volume of intravenous fluid. 
Colloid prehydration may be promising, but still deserves further study. Ueyama and 
colleagues demonstrated that the incidence of hypotension was 75% in those who received 
lactated Ringer's, 58% in those who received 500 mL of hydroxyethylstarch, and only 17% in 
those who received 1000 mL of hydroxyethylstarch [69]. Future studies should address the 
use of colloids in the obstetric setting in order to demonstrate efficacy and safety. 
3.5 Rationale for the use of vasoconstrictors 
In regard to the use of vasoconstrictors in the obstetric setting especially for spinal 
anesthesia, the literature supports the administration of ephedrine, but suggests that 
phenylephrine is effective in reducing maternal hypotension during neuraxial anesthesia for 
cesarean delivery. The literature is equivocal regarding the relative frequency of patients 
with breakthrough hypotension when infusions of ephedrine are compared with 
phenylephrine; however, lower umbilical cord pH values are reported after ephedrine 
administration as compared to the alpha1-agonist phenylephrine. Although recent data 
indicates that alpha1-agonists are more effective to avoid hypotension following spinal 
anesthesia for cesarean delivery, ephedrine is acceptable for treating hypotension during 
neuraxial anesthesia. Therefore, intravenous ephedrine and phenylephrine are both 
acceptable drugs for treating hypotension during neuraxial (spinal or epidural) anesthesia. 
In the absence of maternal bradycardia, phenylephrine may be preferable because of 
improved fetal acid-base status in uncomplicated pregnancies. Of note, some countries 
routinely use metaraminol as an alpha1-agonist instead of phenylephrine in the obstetric 
setting without significant adverse events. This drug seems to be similarly effective as 
phenylephrine. Of note, prophylactic intravenous ephedrine or phenylephrine before spinal 
anesthetic placement has been studied to prevent hypotension, and is generally not 
recommended because of the risk of reactive hypertension [71,72].  
4. Recovery from anesthesia 
4.1 Postoperative (post-cesarean) analgesia: the role of neuraxial opioids  
For improved postoperative analgesia after cesarean delivery during epidural anesthesia, 
the literature supports the use of epidural opioids compared with intermittent injections of 
intravenous or intramuscular opioids. However, a higher frequency of pruritus was found 
with epidural opioids. The literature is insufficient to evaluate the impact of epidural 
opioids compared with intravenous PCA. In addition, the literature is insufficient to 
evaluate spinal opioids compared with parenteral opioids. However, there is sufficient 
evidence that neuraxial opioids improve postoperative analgesia and maternal satisfaction. 
Therefore, we can argue that, for postoperative analgesia after neuraxial anesthesia for 
cesarean delivery, neuraxial opioids are preferred over intermittent injections of parenteral 
opioids [6]. Studies are equivocal regarding doses regimen, especially for epidural opioids 
(morphine). In spinal anesthesia for cesarean delivery, morphine doses are usually between 
60 and 100 µg. Epidural morphine is usually administered in doses between 2 and 3 mg. 
However, controversy exists and new studies regarding efficacy and adverse effects are 
warranted.    
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4.2 Oral intake, removal of urinary catheter and discharge 
Mangesi and Hofmeyr performed a systematic review of six randomized clinical trials 
comparing early with delayed oral intake of fluids and foods after cesarean delivery [73]. 
The authors found that the early consumption (within 4 to 8 hours) was associated with a 
shorter time to return of bowel sounds and a shorter hospital stay. No differences were 
reported in nausea and vomiting, abdominal distention, time to bowel activity, paralytic 
ileus, or need for analgesia.  
There are no differences in the incidence of urinary retention after general anesthesia and 
epidural anesthesia following cesarean delivery [74]. Risk factors for postpartum urinary 
retention after cesarean delivery include the use of postoperative opioid analgesia 
(particularly when given via an epidural catheter), multiple gestations, and a low body mass 
index [75]. Most urinary catheters are removed either immediately following cesarean 
delivery, before discharge from the postoperative care unit or within 24 hours, but there are 
no differences between these options in regard to postoperative urinary retention, infection, 
dysuria, urgency, fever, or length of hospital stay [76]. 
In regard to the postoperative discharge, the anesthesiologist should routinely assess for 
recovery of motor and sensory function if a neuraxial technique was administered. Patients 
should be reassured that breast-feeding is safe, even after general anesthesia, and that 
postoperative analgesics have a favorable safety profile. Early mobility and ambulation 
should be stimulated. 
5. Cesarean delivery: Anesthetic complications 
The main anesthetic complications in cesarean delivery include, but are not limited to: 
hypotension, failure of neuraxial blockade, high blockade levels, dyspnea, nausea and 
vomiting, postoperative pain, pruritus, and shivering.   
Hypotension is a common consequence of neuraxial anesthetic techniques and, when severe 
and sustained, can lead to impairment of uteroplacental perfusion, resulting in fetal 
hypoxia, acidosis, and neonatal depression [77]. Severe maternal hypotension can also have 
adverse maternal outcomes, including unconsciousness, pulmonary aspiration, apnea, 
bradycardia, and even cardiac arrest. The definition of maternal hypotension is 
controversial, but many investigators accept the following definition: a decrease in systolic 
blood pressure of more than 20% from baseline measurements or a systolic blood pressure 
lower than 100 mmHg [78]. Neuraxial anesthetic techniques produce hypotension through 
blockade of sympathetic nerve fibers, which control vascular smooth muscle tone. 
Preganglionic sympathetic fiber blockade primarily causes an increase in venous 
capacitance, which shifts a major portion of blood volume into the splanchnic bed and the 
lower extremities, thereby reducing venous return to the heart. The rate and extent of the 
sympathetic involvement, and subsequently the severity of hypotension, are determined by 
the onset and spread of the neuraxial blockade [79]. Consequently, hypotension may be less 
common with epidural anesthesia than with spinal anesthesia because of the slower onset of 
blockade. The delayed onset of hypotension with epidural anesthesia may also allow earlier 
treatment before hypotension becomes more severe. 
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A failure of neuraxial blockade can be defined as blockade insufficient in extent, density, or 
duration to provide anesthesia for cesarean delivery. Approximately 4% to 13% of epidural 
and 0.5% to 4% of spinal anesthetics fail to provide sufficient anesthesia for the initiation or 
completion of cesarean delivery [33,80]. Epidural techniques are more often associated with 
failure, given the fact that the catheter is often placed during early labor, and over time the 
catheter may migrate out of the epidural space. Factors that may correlate with failed 
extension of labor epidural anesthesia for cesarean delivery include a higher number of 
bolus doses for the provision of labor analgesia, patient characteristics (e.g., obesity, catheter 
positioning), and the time elapsed between placement of the catheter and cesarean delivery 
[33,80]. 
It is not uncommon for the parturient to report mild dyspnea or reduced ability to cough, 
especially if the neuraxial blockade has achieved higher than a T4 level. If impaired 
phonation, unconsciousness, respiratory depression, or significant impairment of ventilation 
occurs, administration of general anesthesia is recommended. High neuraxial blockade may 
also result in cardiovascular collapse, including severe bradycardia and hypotension. This 
complication may be caused by several mechanisms, including an exaggerated spread of 
spinal or epidural drugs and unintentional intrathecal or subdural administration of an 
“epidural dose” of local anesthetic. 
Nausea and vomiting are regulated by the chemoreceptor trigger zone and the vomiting 
center, which are located in the area postrema and the medullary lateral reticular formation, 
respectively. The vomiting center receives impulses from the vagal sensory fibers in the 
gastrointestinal tract, the semicircular canals and ampullae (labyrinth) of the inner ear, 
higher cortical centers, the chemoreceptor trigger zone, and intracranial pressure receptors. 
Impulses from these structures are influenced by dopaminergic, muscarinic, tryptaminergic, 
histaminic, and opioid receptors, which are subsequently the targets for antiemetic agents. 
Efferent impulses from the vomiting center are transmitted through the vagus, phrenic, and 
spinal nerves to the abdominal muscles, which causes the physical act of vomiting [81]. 
Preventing maternal hypotension may be the best means of preventing nausea and 
vomiting. Additionally, several options exist for the pharmacologic prophylaxis of nausea 
and vomiting, and several different classes of drugs are available. Although various 
algorithms have been developed to prevent postoperative nausea and vomiting, primarily 
targeting the nonpregnant patient population, none has been universally successful [82]. 
However, the prophylactic use of these agents either before or after cord clamping during 
cesarean delivery with neuraxial anesthesia has been demonstrated to be highly effective. 
Notably, multimodal therapies combining different medications may eventually prove the 
most effective. Several drugs have been shown to be effective, but most frequently used 
include intravenous ondansetron 4 mg after cord clamping, metoclopramide 10 mg prior to 
surgery or after cord clamping, droperidol 0.625 – 1.25 mg at end of surgery, 
dimenhydrinate 25 – 50 mg, and/or dexamethasone 4 – 8 mg, both possibly after cord 
clamping or at end of surgery.  
Postoperative pain may have at least two components, somatic and visceral. A multimodal 
approach seems to provide the most effective post-cesarean delivery analgesia. Such an 
approach often includes administration of a nonsteroidal anti-inflammatory drug (NSAID), 
acetaminophen and dipyrone. Concerns have been expressed regarding possible adverse 
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effects (platelet dysfunction, uterine atony), but these agents are widely used and seem to be 
safe. Some investigators have expressed concern about the role of NSAIDs on breast-
feeding, but the American Academy of Pediatrics has stated that ibuprofen and ketorolac 
are compatible with breast-feeding [83]. 
The administration of opioids can cause pruritus. The incidence is as high as 30% to 100%, 
and pruritus is more commonly observed when opioids are administered spinally than 
epidurally. Pruritus is typically self-limited and may be generalized or localized to regions 
of the nose, face, and chest. Opioid-induced pruritus appears to be influenced by the 
particular combination of local anesthetic and opioid; of interest, the addition of epinephrine 
to an opioid–local anesthetic solution appears to augment the pruritus [84]. Notably, this 
side effect does not represent an allergic reaction to the neuraxial opioid. If flushing, 
urticaria, rhinitis, bronchoconstriction, or cardiac symptoms also occur, allergic reaction to 
another drug should be considered as a differential diagnosis. The cause of neuraxial 
opioid–induced pruritus is not known, although multiple theories have been proposed. 
They include μ-opioid receptor stimulation at the medullary dorsal horn, antagonism of 
inhibitory transmitters, and activation of an “itch center” in the central nervous system [85]. 
Pharmacologic prophylaxis or treatment of pruritus may include an opioid antagonist, an 
opioid agonist/antagonist, droperidol, a serotonin antagonist (e.g., ondansetron), and/or a 
subhypnotic dose of propofol [85]. Yeh and colleagues observed that ondansetron 
significantly reduced the incidence of spinal morphine–induced pruritus [86]. Although 
opioid antagonists, such as naltrexone and naloxone, and partial agonist/antagonists, such 
as nalbuphine, are probably the most effective treatments for pruritus, the use of any of 
these agents, either as a single dose or in continuous intravenous infusion, may also reverse 
analgesia. Antihistamines are often prescribed but are largely ineffective because the 
mechanism of pruritus is not related to histamine release. 
Intraoperative and postoperative shivering may also have several etiologies but is usually 
related to a decrease in central temperature related to peripheral vasodilation. Several 
treatments are effective, but most frequently used include intravenous meperidine 10 - 30 
mg, clonidine 15 - 150 µg, and alfentanil up to 250 µg [87].  
6. Anticoagulation, coagulopathies and regional anesthesia in obstetrics 
Concern exists that an epidural/spinal hematoma may develop after the administration of 
neuraxial anesthesia in patients with coagulopathy or using anticoagulants. There are only a 
few published cases of epidural hematoma after the administration of neuraxial anesthesia 
in pregnant patients [88,89]. This fact suggests that epidural hematoma after neuraxial 
anesthesia either is very uncommon or is underreported. However, in view of the serious 
effects of an epidural hematoma, the risks and benefits of performing neuraxial anesthesia 
should be carefully considered in a patient with either clinical or laboratory evidence of 
coagulopathy or pregnant women using anticoagulants.  
Clearly, severe coagulopathy represents a well-known contraindication to the 
administration of neuraxial anesthesia, even in obstetric patients. The anesthesiologist can 
use laboratory tests (e.g., prothrombin time/International Normalized Ratio, partial 
thromboplastin time, activated clotting time measurements or thromboelastography) to 
assess the extent of anticoagulation and the effectiveness of reversal in patients receiving 
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standard unfractionated heparin or oral anticoagulation therapy. If use of a neuraxial 
anesthetic technique is considered in a patient with a congenital coagulopathy, results of the 
factor assays should be within the normal range before neuraxial anesthesia administration 
[90].  
Thrombocytopenia is relatively common in pregnant women with severe preeclampsia. 
Asymptomatic thrombocytopenia also may occur in healthy obstetric patients. Previous 
studies have reported that administration of neuraxial anesthesia is safe in healthy pregnant 
women with thrombocytopenia (i.e., platelet count less than 100,000/mm3). In this context, 
the anesthesiologist should always consider the following factors: clinical evidence of 
bleeding, recent platelet count, recent changes in the platelet count, quality of platelets, 
coagulation factors, and, most importantly, the risk/benefit ratio of performing neuraxial 
anesthesia [91].  
Most pregnant women who require long-term anticoagulation receive low molecular weight 
heparin (LMWH) or standard unfractionated heparin throughout pregnancy. LMWH (e.g., 
enoxaparin) is considered to be more efficacious for thromboprophylaxis than standard 
unfractionated heparin and has been used safely in pregnant women [92]. However, several 
cases of epidural/spinal hematoma after neuraxial anesthesia in non-obstetric patients 
receiving LMWH have been reported [93,94]. This apparent increase in the risk for an 
epidural hematoma may be related to the use of higher doses of LMWH and its relatively 
greater bioavailability and longer half-life in comparison with standard unfractionated 
heparin. Guidelines recommend that in patients receiving LMWH for thromboprophylaxis, 
needle placement should occur at least 10 to 12 hours after the last LMWH dose. In patients 
receiving higher doses of LMWH (e.g., enoxaparin 1 mg/kg every 12 hours or enoxaparin 
1.5 mg/kg daily), needle placement should not occur until at least 24 hours after the last 
dose of LMWH [92]. In patients receiving a single daily dose of LMWH 
thromboprophylaxis, the first postoperative LMWH dose should be administered only 6 to 8 
hours after surgery. An indwelling epidural catheter may be safely maintained in these 
patients; however, it should be removed at least 12 hours after the last dose of LMWH, and 
the next dose of LMWH should be administered at least 2 hours after catheter removal. In 
patients receiving higher doses of LMWH, the first dose of LMWH should be delayed for 24 
hours postoperatively, and an indwelling catheter should be removed at least 2 hours before 
initiation of LMWH therapy [92].  
There is a large experience with the use of standard unfractionated heparin and a large 
number of patients have received neuraxial anesthesia while receiving subcutaneous 
thromboprophylaxis with standard unfractionated heparin, without significant neurologic 
complications. In this context, guidelines recommend that subcutaneous 
thromboprophylaxis with standard unfractionated heparin does not contraindicate the use 
of neuraxial anesthesia. However, the platelet count should be assessed before the 
administration of neuraxial anesthesia or catheter removal in patients who have received 
standard unfractionated heparin for more than 4 days [92].  
If oral anticoagulants (e.g., warfarin) are administered during pregnancy, it is usually 
replaced by LMWH or standard unfractionated heparin before the onset of labor. If a 
pregnant woman begins labor while she is still taking oral anticoagulants, the effects can be 
reversed by intramuscular administration of vitamin K. Because reversal of anticoagulation 
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requires time for the synthesis of new procoagulants, acute reversal can be accomplished by 
the administration of 10 to 20 mL/kg of fresh frozen plasma [91].  
Low-dose aspirin does not significantly prolong the bleeding time in pregnant women [95]. 
Therefore, there is no recommendation to obtain a bleeding time measurement in patients 
who have received low-dose aspirin during pregnancy. Moreover, a large number of 
women receiving low-dose aspirin therapy for the prevention or treatment of preeclampsia 
have undergone epidural analgesia for labor and delivery without complications [96].  
Notably, the contraindication of regional anesthesia in pregnant women displaying mild or 
isolated abnormalities in blood coagulation tests is somewhat controversial. However, it is 
clear that the prophylactic administration of low-molecular-weight heparin is a clinical risk 
factor that warrants caution in the administration of neuraxial anesthesia. The 
anesthesiologist should weigh the risks and benefits of neuraxial anesthesia and general 
anesthesia for the individual patient. It is preferable not to administer neuraxial anesthesia 
to a patient with a persistent laboratory coagulation abnormality. However, in selected 
circumstances, neuraxial anesthesia may be offered to a patient with an isolated laboratory 
abnormality and no clinical evidence of coagulopathy. In such patients, frequent neurologic 
examinations should be performed to facilitate the early detection of an epidural hematoma 
during the postpartum period. 
7. Contraindications to regional (neuraxial) anesthesia in obstetrics  
Regional (neuraxial) anesthesia is usually considered the first choice for most cesarean 
delivery procedures. However, similarly to other non-obstetric procedures, some 
contraindications can be pointed out. Contraindications for neuraxial anesthesia in the 
obstetrics setting usually include the following: patient refusal or inability to cooperate, 
severe coagulopathy, uncorrected maternal hypovolemia or significant hemodynamic 
instability, increased intracranial pressure, skin or soft tissue infection at the site of needle 
puncture. Severe anatomical abnormalities of the spine could also be related to significant 
difficulties to provide neuraxial anesthesia. The often-cited relative contraindication of 
preexisting neurologic disease is not usually based on medical criteria but rather on legal 
considerations [97]. The anesthesiologist should always weigh the risks and benefits of 
neuraxial anesthesia for each patient. 
8. Summary of the main recommendations in anesthesia for cesarean delivery: the 
anesthetic procedure can change obstetric outcomes? 
8.1 Perianesthetic evaluation 
- Before providing anesthesia care, conduct history a focused on relevant obstetric 
history, maternal health and anesthetic history; 
- Brief physical examination focused on airway and heart and lung examination and back 
examination when neuraxial anesthesia is planned;  
- Baseline blood pressure measurement (at least two measures); 
- Order a platelet count, blood type, and cross-match based on a patient’s history, 
physical examination, clinical signs, and anticipated hemorrhagic complications. Of 
note, a routine platelet count and blood cross-match are not necessary in the healthy 
parturient and uncomplicated parturients; 
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- Oral intake of modest amounts of clear liquids may be allowed for uncomplicated 
patient undergoing elective cesarean delivery up to 2 h before induction of anesthesia. 
Pregnant women with additional risk factors for aspiration may have further 
restrictions of oral intake, determined on a case-by-case basis. Women undergoing 
elective cesarean delivery should undergo a fasting period for solids of 6–8 h depending 
on the type of food ingested;  
- In selected patients, consider preanesthetic administration of nonparticulate antacids 
(sodium citrate), H2 receptor antagonists (ranitidine), and/or metoclopramide for 
aspiration prophylaxis; 
8.2 Anesthesia for cesarean delivery 
- Equipment and support personnel available in the delivery operating room should be 
comparable to those available in the main operating rooms; 
- Equipment and support for the treatment of potential complications (e.g., failed 
intubation, hypotension, etc) should be available in the delivery operating room; 
- Appropriate equipment and support personnel should be available to postoperative 
care for obstetric patients recovering from major neuraxial or general anesthesia; 
- Neuraxial techniques are preferred to general anesthesia for most cesarean deliveries. 
The decision to use a particular anesthetic technique should be individualized based on 
anesthetic, obstetric, or fetal risk factors, the preferences of the patient, and the 
judgment of the anesthesiologist; 
- If spinal anesthesia is chosen, pencil-point spinal needles should be used instead of 
cutting-bevel spinal needles; 
- An indwelling epidural catheter may provide equivalent onset of anesthesia compared 
with initiation of spinal anesthesia for urgent cesarean delivery 
- General anesthesia may be the most appropriate choice in some circumstances (e.g., 
profound fetal bradycardia, ruptured uterus, severe hemorrhage, severe placental 
abruption); 
- Intravenous fluid preloading may be used to reduce the frequency of maternal 
hypotension following spinal anesthesia for cesarean delivery. However, initiation of 
spinal anesthesia should not be delayed to administer a fixed volume of intravenous fluid; 
- Uterine displacement (usually left displacement) should be maintained until delivery 
regardless of the anesthetic technique used;  
- Intravenous ephedrine and alpha1-agonists (phenylephrine or metaraminol) are both 
acceptable drugs for treating hypotension during neuraxial anesthesia. In the absence of 
maternal bradycardia, alpha1-agonists, particularly phenylephrine, may be preferable 
because of improved fetal acid-base status in uncomplicated pregnancies; 
8.3 Recovery from cesarean delivery 
- For postoperative analgesia after neuraxial anesthesia for cesarean delivery, neuraxial 
opioids are preferred over intermittent injections of parenteral opioids 
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